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A laboratory colony of human body lice was experimentally infected by feeding on rabbits made artificially
bacteremic with a green fluorescent protein-expressing Bartonella quintana. B. quintana was detected in the gut
and feces until death but not in the eggs. The life span of the lice was not modified. The rabbit model should
provide valuable clues to the role of lice in the transmission of B. quintana.
Bartonella quintana is a fastidious gram-negative bacterium
that is regarded as a reemerging human pathogen (1) and is
responsible for various human diseases (12). Although trench
fever, the first clinical manifestation of B. quintana infection
to be recognized (13), affected thousands of soldiers during
World Wars I and II, medical interest in trench fever waned for
almost 30 years because the disease was only rarely encoun-
tered. In the 1990s, B. quintana was identified as an agent of
bacillary angiomatosis in AIDS patients (17), endocarditis (5,
16, 18), chronic bacteremia (3, 19), and chronic lymphadenop-
athy (15). These diseases are associated with homelessness or
cramped, unhygienic circumstances, together with cold weath-
er and the presence of body lice. The role of lice had been
observed as early as 1920 (4). Various experiments have dem-
onstrated that the disease could be induced in human volun-
teers (20) and Macacus rhesus monkeys (14) by injection of
B. quintana and that the bacterium multiplied in the gut lumen
of naturally (21) or intrarectally (8) infected lice without in-
terfering with viability and was excreted in their feces (4, 8).
However, despite growing interest in louse-transmitted dis-
eases, there is no currently available experimental model to
describe the relationship between B. quintana and the louse.
GFP-expressing B. quintana. B. quintana strain Oklahoma
(ATCC 49793) was obtained from the American Type Culture
Collection (Rockville, Md.) and cultivated as previously de-
scribed (10). Plasmid pJMBGFP, containing the B. bacillifor-
mis flagellin promoter and a Rep origin of replication obtained
from pBBR1-MCS2 (9) (Table 1), was provided by James M.
Battisti (Division of Biological Sciences, University Montana,
Missoula, Mont.). It was extracted and purified from Esche-
richia coli using a Midi Prep kit (Qiagen, Inc., Chatsworth,
Calif.) and then adjusted to 0.5 mg/ml. Transformation proce-
dures were as previously described (6). The transformed bac-
teria were cultivated on 5% sheep blood agar containing 25 mg
of kanamycin sulfate per ml and were further verified as B.
quintana by PCR amplification of the 16S-23S rDNA inter-
genic spacer (its) followed by sequencing (6). The presence of
plasmid DNA was checked as previously described (6).
Optimal transformation efficiencies were obtained at 6 ms
for a field strength of 12.5 kV/cm and a plasmid DNA amount
of 60 to 80 ng but were low, ranging from 3 3 1025 to 7 3 1025.
Colonies of green fluorescent protein (GFP)-expressing B. quin-
tana began to appear at aproximately 12 to 16 days following
electroporation, which represents a growth lag time of approx-
imately 8 to 12 days compared with the growth of untrans-
formed bacteria on plate-to-plate passage. The colonies were
typically smaller than those formed by untransformed B. quin-
tana at the same stage of growth. When the colonies were
subcultured on selective media, GFP expression was conserved
after 15 passages, suggesting that plasmid maintenance was
stable in the presence of antibiotic, but was lost after 5 pas-
sages in the absence of antibiotic. No growth was obtained on
selective media with wild-type B. quintana prepared under the
same conditions or B. quintana electroporated without DNA.
Sequencing of PCR-products amplified from the its revealed
100% identity to known sequences of B. quintana, confirming
that the transformants were B. quintana.
Experimental body louse infection. Body lice (Pediculus hu-
manus corporis, strain Orlando) were kindly provided by D.
Richard-Lenoble (Laboratoire de Parasitologie, Faculté de
Médecine, Tours, France). A colony of lice was established and
nourished daily on the shaved abdomen of specific-pathogen-
free (SPF) New Zealand White rabbits (Fig. 1a). The lice were
shown to be free from B. quintana by periodic its PCR ampli-
fication of samples from their gut and feces. One SPF rabbit,
designated R1, was first injected intravenously with 2.5 ml of a
solution of 10 mg of kanamycin (Sigma, St. Louis, Mo.) per ml,
and 15 min later was injected with 20 ml of a suspension of 106
CFU of pJMBGFP-expressing B. quintana per ml in saline,
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before 800 15-day-old lice, half of which were female, were
allowed to feed on its abdomen. The lice were then kept at
30°C and 70% humidity. The day of infection was referred to
as day 1. On the following days, lice were allowed to feed daily
on a second SPF rabbit designated R2. Before the lice were
allowed to feed each day, R2 was injected intravenously each
day with 2.5 ml of 10 mg of kanamycin sulfate (Sigma) per ml.
To detect B. quintana, its amplification by PCR and culture on
kanamycin-containing agar for up to 60 days at 37°C under a
5% CO2 atmosphere were performed on blood drawn from the
infected rabbit after the lice had fed then every day for 5 days,
and then once a week for 2 months. Similar tests were per-
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Genotype or relevant characteristics Reference or source
Strains
E. coli DH5 F2 (F80dlacZDM15) D(lacZY AargF)U169 deoR recA1 endA1 hsdR17 (rK
2 mK
1), supE44
l-thi-1 gyrA96 relA1 l-CH616
Gibco-BRL (7)
B. quintana ‘Oklahoma’
Plasmids
pBBR1-MCS2 Kmr Mob Rep origin, Bartonella shuttle vector Michael Kovach (7)
pFPV25 Source of promoterless GFP (gfpmut3a) Raphael Valdivia
PJMBGFP PBBR1-MCS2 with a 970-bp HindIII fragment containing B. bacilliformis flagellin promoter
(fla-pro) upstream of gfpmut3a
James M. Battitsti (2)
FIG. 1. Experimental model of body louse infection by GFP-expressing B. quintana. (a) Pediculus humanus humanus feeding on a rabbit; (b)
fluorescent colony isolated on selective agar from an infected louse 10 days after the initial infection; (c) autofluorescence of body lice; (d)
immunohistological detection of B. quintana. Note the numerous erythrocytes and the clusters of bartonellae in the intestine lumen (red clumps)
and against the intestine wall (blue). Streptavidin-biotin-peroxidase method, polyclonal rabbit anti-B. quintana used at a dilution of 1:400, hemalun
counterstain. Magnification, 3660.
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formed on 15 lice harvested after feeding on the infected
rabbit, 15 lice harvested daily for 1 week and twice a week after
that until no lice from the first generation remained, and, when
present, eggs, larvae, and feces. Blood samples drawn from the
infected rabbit (R1) were positive for B. quintana by culture
and PCR on days 1 and 2, with 2 3 104/ml and 7 3 102
CFU/ml, respectively, but were negative on day 3 and at all
later times. On follow-up, the rabbit did not present with any
abnormal symptoms but developed an anti-B. quintana immu-
noglobulin G response by day 15, with a titer of 1:400 as
determined by indirect immunofluorescence. Blood drawn
from rabbit R2 was negative by both culture and PCR, and
they did not seroconvert. GFP-expressing B. quintana was
grown and PCR amplified from all groups of lice. Between 7
and 20 CFU of Bartonella (mean 6 standard deviation 5
16.3 6 2.9) was obtained from each louse (Fig. 1b). The num-
ber of CFU did not decrease over time. B. quintana was also
grown and PCR amplified from fecal samples harvested
throughout the experiment. Qualitative but not quantitative
analysis of the colonies grown from infected feces was per-
formed. Only fluorescent colonies grew. The GFP marker was
therefore very useful for directly identifying B. quintana colo-
nies (Fig. 1B). None of the uninfected control lice were posi-
tive by culture or PCR analysis. The average daily number of
eggs from the infected group was 682.8 6 335.1 and was not
significantly different from the 705.2 6 357.9 observed in the
control group (P 5 0.51). No growth or PCR amplification of
B. quintana was obtained from the 300 eggs and 100 larvae
tested. Unfortunately, we observed that body lice were
autofluorescent, and therefore detection of GFP-expressing
Bartonella was not possible (Fig. 1c).
For histological examination, five lice collected on each of
days 0, 3, 5, 7, and then once a week were fixed in 10% formalin
overnight, paraffin embedded, and cut to 5-mm thickness. He-
matoxylin-eosin stain was used to visualize the gut system, and
Warthin-Starry stain was used to detect bartonellae. Immuno-
chemistry using anti-B. quintana polyclonal antibodies (11) was
performed on 5-mm-thick formalin-fixed and paraffin-embed-
ded gut sections. For each section, a negative control was
prepared using gut sections from uninfected lice. The gut sys-
tem was easy to recognize by its thin wall and large lumen.
Bartonella were identified as dense clusters of bacteria in the
intestinal lumen. Masses of bacteria occupied an extracellular
location (Fig. 1d).
To determine whether B. quintana would influence louse
mortality, 200 infected lice, half of which were female, were fed
daily on rabbit R2 and were compared with 200 control lice,
half of which were female, that fed only on an SPF rabbit (R3).
The number of dead lice in both groups was compared using a
Kaplan-Meier life table (GB-STAT version 6.5; Dynamic Sys-
tems Inc., Silver Springs, Md.), and the equality of survival
between the two populations was estimated using the general-
ized Wilcoxon test. No significant difference in the mortality
rate was observed between infected and control lice (P 5 0.49)
(Fig. 2).
In conclusion, we report the first experimental animal model
of body louse infection by using a laboratory colony of lice
feeding on a rabbit with a GFP-expressing B. quintana bacte-
remia. The lice maintained an asymptomatic extracellular in-
fection inside their gut during their entire life but did not
transmit B. quintana to the next generation, supporting the role
of body lice as vectors, but not reservoirs, for B. quintana. This
rabbit model of human body louse infection may be valuable
for other louse-transmitted pathogens.
We thank James M. Battisti, Michael Kovacs, and Raphael Valdivia
for kindly providing plasmids.
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